Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: A pilot study

Pituitary

Volumn 17, Issue 3, 2014, Pages 232-239

  Jiang, Xiao Bing ^a   Li, Cui Ling ^a   He, Dong Sheng ^a   Mao, Zhi Gang ^a   Liu, Dong Hong ^a   Fan, Xiang ^a   Hu, Bin ^a   Zhu, Yong Hong ^b   Wang, Hai Jun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atherosclerosis; Endothelium; Inflammation; Metabolic profile; Pituitary adenoma

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; C REACTIVE PROTEIN; ESTRADIOL; FIBRINOGEN; FOLLITROPIN; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; LIPID; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE; THYROTROPIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; FREE THYROXINE INDEX; HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; MALE; PILOT STUDY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; THYROTROPIN BLOOD LEVEL; BLOOD; CAROTID ARTERY DISEASE; HYPOPHYSIS TUMOR; INFLAMMATION; METABOLISM; PATHOLOGY; RISK FACTOR; SEXUAL DEVELOPMENT; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADULT; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; MALE; PILOT PROJECTS; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; RISK FACTORS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84905683661     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-013-0495-z     Document Type: Article

References (30)

1. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91:4769-4775 (Pubitemid 44917305)
2. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:273-288
3. Klibanski A (2010) Clinical practice. Prolactinomas. N Engl J Med 362:1219-1226
4. Dos SSC, Barbosa FR, Lima GA, Warszawski L, Fontes R, Domingues RC, Gadelha MR (2011) BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Obesity (Silver Spring) 19:800-805
5. Berinder K, Nystrom T, Hoybye C, Hall K, Hulting AL (2011) Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy. Pituitary 14:199-207
6. Schmid C, Goede DL, Hauser RS, Brandle M (2006) Increased prevalence of high body mass index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma. Swiss Med Wkly 136:254-258
7. Serri O, Li L, Mamputu JC, Beauchamp MC, Maingrette F, Renier G (2006) The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin Endocrinol (Oxf) 64:366-370
8. Doknic M, Pekic S, Zarkovic M, Medic-Stojanoska M, Dieguez C, Casanueva F, Popovic V (2002) Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 147:77-84 (Pubitemid 34814743)
9. de Assuncao ARL, Campos SM, Miranda PA, Bizzi MF, Sales DAP, Giannetti AV, Ribeiro-Oliveira A (2012) Prolactinoma: a condition associated with hypoadiponectinemia. Horm Metab Res 44:832-838
10. Jiang XB, He DS, Mao ZG, Fan X, Lei N, Hu B, Song BB, Zhu YH, Wang HJ (2013) BMI, apolipoprotein B/apolipoprotein A-I ratio, and insulin resistance in patients with prolactinomas: a pilot study in a Chinese cohort. Tumour Biol 34:1171-1176
11. Yavuz D, Deyneli O, Akpinar I, Yildiz E, Gozu H, Sezgin O, Haklar G, Akalin S (2003) Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic premenopausal women. Eur J Endocrinol 149:187-193 (Pubitemid 37120990)
12. Merkle CJ, Schuler LA, Schaeffer RJ, Gribbon JM, Montgomery DW (2000) Structural and functional effects of high prolactin levels on injured endothelial cells: evidence for an endothelial prolactin receptor. Endocrine 13:37-46
13. Sauro MD, Zorn NE (1991) Prolactin induces proliferation of vascular smooth muscle cells through a protein kinase C-dependent mechanism. J Cell Physiol 148:133-138 (Pubitemid 21910135)
14. Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I, Lykka M, Kyrkou K, Rizos D, Creatsa M, Christodoulakos G, Alevizaki M, Sfikakis PP (2009) Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension 54:98-105
15. Reuwer AQ, van Eijk M, Houttuijn-Bloemendaal FM, van der Loos CM, Claessen N, Teeling P, Kastelein JJ, Hamann J, Goffin V, von der Thusen JH (2011) The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis? J Endocrinol 208:107-117
16. Carrero JJ, Kyriazis J, Sonmez A, Tzanakis I, Qureshi AR, Stenvinkel P, Saglam M, Stylianou K, Yaman H, Taslipinar A (2012) Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin J Am Soc Nephrol 7:207-215
17. Koivistoinen T, Virtanen M, Hutri-Kahonen N, Lehtimaki T, Jula A, Juonala M, Moilanen L, Aatola H, Hyttinen J, Viikari JS (2012) Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the cardiovascular risk in Young Finns Study and the Health 2000 Survey. Atherosclerosis 220:387-393
18. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847 (Pubitemid 28213628)
19. Skipworth RJ, Moses AG, Sangster K, Sturgeon CM, Voss AC, Fallon MT, Anderson RA, Ross JA, Fearon KC (2011) Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer. Support Care Cancer 19:391-401
20. Katznelson L, Kleinberg D, Vance ML, Stavrou S, Pulaski KJ, Schoenfeld DA, Hayden DL, Wright ME, Woodburn CJ, Klibanski A (2001) Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clin Endocrinol (Oxf) 54:183-188 (Pubitemid 32193519)
21. Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I, Lykka M, Kyrkou K, Rizos D, Creatsa M, Christodoulakos G, Alevizaki M, Sfikakis PP (2009) Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension 54:98-105
22. Stumpe KO, Kolloch R, Higuchi M, Kruck F, Vetter H (1977) Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control. Lancet 2:211-214 (Pubitemid 8120638)
23. Montes DOP, Macotela Y, Nava G, Lopez-Barrera F, de la Escalera GM, Clapp C (2005) Prolactin stimulates integrin-mediated adhesion of circulating mononuclear cells to endothelial cells. Lab Invest 85:633-642
24. Rocha VZ, Libby P (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6:399-409
25. Ochoa-Amaya JE, Malucelli BE, Cruz-Casallas PE, Nasello AG, Felicio LF, Carvalho-Freitas MI (2011) Dual effects of hyperprolactinemia on carrageenan-induced inflammatory paw edema in rats. Neuroimmunomodulat 18:245-253
26. Reuwer AQ, Sondermeijer BM, Battjes S, van Zijderveld R, Stuijver DJ, Bisschop PH, Twickler MT, Meijers JC, Schlingemann RO, Stroes ES (2012) Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study. Pituitary 15:472-481
27. Ben-Jonathan N, Hugo ER, Brandebourg TD, LaPensee CR (2006) Focus on prolactin as a metabolic hormone. Trends Endocrinol Metab 17:110-116
28. Johnston DG, Alberti KG, Nattrass M, Burrin JM, Blesa-Malpica G, Hall K, Hall R (1980) Hyperinsulinaemia in hyperprolactinaemic women. Clin Endocrinol (Oxf) 13:361-368 (Pubitemid 10004303)
29. Ferrannini E, Mari A (1998) How to measure insulin sensitivity. J Hypertens 16:895-906 (Pubitemid 28367943)
30. Dahlen EM, Lanne T, Engvall J, Lindstrom T, Grodzinsky E, Nystrom FH, Ostgren CJ (2009) Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med 26:384-390